Matinas BioPharma Holdings, Inc. (MTNB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Matinas BioPharma Holdings, Inc. (MTNB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.1M, listed on AMEX, employing roughly 3 people, carrying a beta of 1.62 to the broader market. Matinas BioPharma Holdings, Inc. Led by Jerome D. Jabbour, public since 2014-07-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for MTNB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →